Article Information
History
- September 9, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Adam Penn-Nicholson1,*,
- Stanley Kimbung Mbandi1,*,
- Ethan Thompson2,*,
- Simon C. Mendelsohn1,*,
- Sara Suliman1,3,
- Novel N. Chegou4,
- Stephanus T. Malherbe4,
- Fatoumatta Darboe1,
- Mzwandile Erasmus1,
- Willem A. Hanekom1,
- Nicole Bilek1,
- Michelle Fisher1,
- Stefan H. E. Kaufmann5,6,
- Jill Winter7,
- Melissa Murphy1,
- Robin Wood8,
- Carl Morrow8,
- Ildiko Van Rhijn3,
- Branch Moody3,
- Megan Murray9,
- Bruno B. Andrade10,
- Timothy R. Sterling11,
- Jayne Sutherland12,
- Kogieleum Naidoo13,14,
- Nesri Padayatchi13,14,
- Gerhard Walzl4,
- Mark Hatherill1,
- Daniel Zak2,
- Thomas J. Scriba1,†,
- the Adolescent Cohort Study team,
- GC6-74 Consortium,
- The ScreenTB and AE-TBC teams,
- CAPRISA IMPRESS team,
- RePORT Brazil Consortium,
- Peruvian Household Contacts Cohort study group
- 1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
- 2Center for Infectious Disease Research, Seattle, WA, USA
- 3Brigham and Women’s Hospital, Division of Rheumatology, Immunity and Inflammation, Harvard Medical School, Boston, USA
- 4DST-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
- 5Max Planck Institute for Infection Biology, Berlin, Germany
- 6Hagler Institute for Advanced Study at Texas A&M University, College Station, TX, USA
- 7Catalysis Foundation for Health, San Ramon, CA, USA
- 8Desmond Tutu HIV Centre, and Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa
- 9Department of Global Health and Social Medicine, and Division of Global Health Equity, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
- 10Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil
- 11Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, USA
- 12Vaccines and Immunity, Medical Research Council Unit, Fajara, the Gambia
- 13Centre for the AIDS Programme of Research in Africa, Durban, South Africa
- 14South African Medical Research Council-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa
- ↵†Corresponding Author:
Thomas J. Scriba. Email: thomas.scriba{at}uct.ac.za
↵* These authors contributed equally